Allogenic γδT Cell
Showing 1 - 25 of >10,000
Non Hodgkin's Lymphoma Trial in Beijing (Allogenic CD19-CAR-?dT cell, Fludarabine, Cyclophosphamide)
Recruiting
- Non Hodgkin's Lymphoma
- Allogenic CD19-CAR-γδT cell
- +2 more
-
Beijing, Beijing, China
- +1 more
Jan 31, 2023
Brain Gliomas Trial in Suzhou (Allogenic B7H3 CAR-?dT cell)
Recruiting
- Brain Gliomas
- Allogenic B7H3 CAR-γδT cell
-
Suzhou, Jiangsu, ChinaDushu Lake Hospital Affiliated to Soochow University
Aug 25, 2023
AML Trial in Wuhan (CAR--?dT cells)
Recruiting
- AML
- CAR--γδT cells
-
Wuhan, Hubei, ChinaTongji Hospital
May 24, 2022
B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- QH103 Cell Injection
- +2 more
-
Hefei, Anhui, ChinaAnhui Provincial Hospital
Sep 21, 2023
Knee Osteoarthritis Trial (Allogenic adipose derived mesenchymal stem cells (AD-MSC), Saline)
Not yet recruiting
- Knee Osteoarthritis
- Allogenic adipose derived mesenchymal stem cells (AD-MSC)
- Saline
- (no location specified)
Jun 26, 2023
Thrombotic Disorder Trial (N-acetyl-cysteine, Busulfan, Cytarabine)
Not yet recruiting
- Thrombotic Disorder
- N-acetyl-cysteine
- +3 more
- (no location specified)
Jun 8, 2023
Acute Lymphoblastic Leukemia, B-cell Lymphoma, Chronic Lymphocytic Leukemia Trial in Xuzhou (allogenic CD19-CAR-NK cells)
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- allogenic CD19-CAR-NK cells
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Feb 11, 2023
Aging Frailty Trial in Abu Dhabi (StromaForte)
Recruiting
- Aging Frailty
- StromaForte
-
Abu Dhabi, United Arab EmiratesBurjeel Medical City
Oct 2, 2023
Hidradenitis Suppurativa Trial in Granada (Injectable suspension of allogeneic adult mesenchymal stem cells, Placebo)
Recruiting
- Hidradenitis Suppurativa
- Injectable suspension of allogeneic adult mesenchymal stem cells
- Placebo
-
Granada, SpainHospital Universitario Virgen de Las Nieves
Jul 6, 2023
Kidney Cancer Trial in Tampa, Atlanta, Nashville (Blood Sparing Protocol, Standard Blood Replacement)
Suspended
- Kidney Cancer
- Blood Sparing Protocol
- Standard Blood Replacement
-
Tampa, Florida
- +2 more
Aug 26, 2022
MDS Trial in Bari, Rozzano (bone marrow withdrawal)
Recruiting
- Myelodysplastic Syndromes
- bone marrow withdrawal
-
Bari, Italy
- +6 more
Oct 10, 2022
AML Trial in Yanda (CAR-?dT)
Recruiting
- AML
- CAR-γδT
-
Yanda, Hebei, ChinaHebei yanda Ludaopei Hospital
Mar 11, 2021
Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)
Withdrawn
- Multiple Myeloma
- Refractory Multiple Myeloma
- nonmyeloablative allogeneic hematopoietic stem cell transplantation
- +7 more
- (no location specified)
Jan 4, 2023
ST Elevation Myocardial Infarction Trial in Jakarta Pusat (Umbilical Cord Mesenchymal Stem Cell transplantation)
Not yet recruiting
- ST Elevation Myocardial Infarction
- Umbilical Cord Mesenchymal Stem Cell transplantation
-
Jakarta Pusat, DKI Jakarta, IndonesiaCipto Mangunkusumo Hospital
Jul 5, 2023
Influence of Timing PTCy in AlloSCT
Not yet recruiting
- Cyclophosphamide Toxicity
- Allogenic Haematopoetic Transplantation
- (no location specified)
Jun 6, 2023
Cardiovascular Diseases Trial in Nassau (Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))
Recruiting
- Cardiovascular Diseases
- Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
-
Nassau, The Bahamas, BahamasThe Partners Clinical Research Centre at The Medical Pavilion
Oct 17, 2023
Leukemia, B-cell Trial in Suzhou (?dT Cell infusion agent)
Recruiting
- Leukemia, B-cell
- γδT Cell infusion agent
-
Suzhou, Jiangsu, ChinaNo.188 Shizi Street
Jan 4, 2021
Osteo Arthritis Knee Trial in Abu Dhabi (Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte))
Recruiting
- Osteo Arthritis Knee
- Human Allogenic Bone-Marrow-Derived Mesenchymal Stromal Cell Product (StromaForte)
-
Abu Dhabi, United Arab EmiratesBurjeel Medical City
Oct 11, 2023
Post-Acute COVID-19 Syndrome Trial in Houston (Stem Cell)
Not yet recruiting
- Post-Acute COVID-19 Syndrome
- Stem Cell
-
Houston, TexasThe University of Texas Health Science Center at Houston
Nov 29, 2023
Patient Blood Management, Cardiovascular Risk, Major Non-cardiac Surgery Trial in Hangzhou (Iron Sucrose, recombinant human
Not yet recruiting
- Patient Blood Management
- +3 more
- Iron Sucrose, recombinant human erythropoietin
- placebo
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital of Zhejiang University Medical Co
Aug 11, 2022
Hematologic Diseases Trial in Hefei (allogeneic ?9d2 T Cells, Fludarabine, Cyclophosphamide)
Recruiting
- Hematologic Diseases
- allogeneic γ9δ2 T Cells
- +3 more
-
Hefei, Anhui, ChinaAnhui Provincial Hospital
Feb 23, 2023
Adenovirus Infections in Allogenic Hematopoietic Cell Transplant
Completed
- Adenovirus Infections, Human
- (no location specified)
Mar 10, 2022
Allogenic Stem Cell Transplantation Trial (SAR445419)
Not yet recruiting
- Allogenic Stem Cell Transplantation
- (no location specified)
Feb 13, 2023
Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, Bortezomib)
Recruiting
- Graft-versus-host Disease
- Cyclophosphamide
- +2 more
-
New York, New YorkNYU Langone Health
Mar 24, 2022